119 related articles for article (PubMed ID: 6146373)
1. Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.
McCreadie RG; Mackie M; Wiles DH; Jorgensen A; Hansen V; Menzies C
Br J Psychiatry; 1984 Jun; 144():625-9. PubMed ID: 6146373
[TBL] [Abstract][Full Text] [Related]
2. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
3. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
Wiles DH; McCreadie RG; Whitehead A
Psychopharmacology (Berl); 1990; 101(2):274-81. PubMed ID: 2349370
[TBL] [Abstract][Full Text] [Related]
5. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Soni SD; Sampath G; Shah A; Krska J
Acta Psychiatr Scand; 1992 May; 85(5):354-9. PubMed ID: 1351333
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic plasma levels.
Van Putten T; Marder SR; Wirshing WC; Aravagiri M; Chabert N
Schizophr Bull; 1991; 17(2):197-216. PubMed ID: 1679251
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of the depot antipsychotics.
Jann MW; Ereshefsky L; Saklad SR
Clin Pharmacokinet; 1985; 10(4):315-33. PubMed ID: 2864156
[TBL] [Abstract][Full Text] [Related]
8. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
[TBL] [Abstract][Full Text] [Related]
9. Prolactin bioassay in schizophrenia before and after neuroleptics.
Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
[TBL] [Abstract][Full Text] [Related]
10. A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
Wistedt B; Jørgensen A; Wiles D
Psychopharmacology (Berl); 1982; 78(4):301-4. PubMed ID: 6818587
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
Turbott J; Villiger J; Hunter L
Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
[TBL] [Abstract][Full Text] [Related]
12. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Viala A; Hou N; Ba B; Durand A; Dufour H; D'Agostino N; Berda C; Jørgensen A
Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH
J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
McKane JP; Robinson AD; Wiles DH; McCreadie RG; Stirling GS
Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
[TBL] [Abstract][Full Text] [Related]
15. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
[TBL] [Abstract][Full Text] [Related]
16. Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics.
Wistedt B; Wiles D; Kolakowska T
Lancet; 1981 May; 1(8230):1163. PubMed ID: 6112518
[No Abstract] [Full Text] [Related]
17. Lowest effective dose of depot neuroleptics.
Hoencamp E; Haffmans PJ; Jansen GS
Br J Psychiatry; 1992 Mar; 160():422-3. PubMed ID: 1348655
[No Abstract] [Full Text] [Related]
18. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Kolakowska T; Williams AO; Ardern M; Reveley MA; Jambor K; Gelder MG; Mandelbrote BM
Br J Psychiatry; 1985 Mar; 146():229-39. PubMed ID: 2859067
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.
Jørgensen A; Andersen J; Bjørndal N; Dencker SJ; Lundin L; Malm U
Psychopharmacology (Berl); 1982; 77(1):58-65. PubMed ID: 6812119
[TBL] [Abstract][Full Text] [Related]
20. Large variations of plasma levels during maintenance treatment with depot neuroleptics.
Tuninger E; Levander S
Br J Psychiatry; 1996 Nov; 169(5):618-21. PubMed ID: 8932892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]